Source: Archives of Pathology and Laboratory Medicine. Unidade: FM
Subjects: FÁRMACOS, IMUNOTERAPIA, ANTINEOPLÁSICOS, APOPTOSE, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHOLL, Lynette M. et al. Programmed Death Ligand-1 Immunohistochemistry— A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society. Archives of Pathology and Laboratory Medicine, v. 140, p. 341-344, 2016Tradução . . Disponível em: http://www.archivesofpathology.org/doi/pdf/10.5858/arpa.2015-0506-SA. Acesso em: 04 nov. 2024.APA
Sholl, L. M., Aisner, D. L., Allen, T. C., Beasley, M. B., Borczuk, A. C., Cagle, P. T., et al. (2016). Programmed Death Ligand-1 Immunohistochemistry— A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society. Archives of Pathology and Laboratory Medicine, 140, 341-344. doi:10.5858/arpa.2015-0506-SANLM
Sholl LM, Aisner DL, Allen TC, Beasley MB, Borczuk AC, Cagle PT, Capelozzi V, Dacic S, Hariri L, Kerr KM, Lantuejoul S, Mino-Kenudson M, Raparia K, Rekhtman N, Roy-Chowdhuri S, Thunnissen E, Tsao MS, Yatabe Y. Programmed Death Ligand-1 Immunohistochemistry— A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society [Internet]. Archives of Pathology and Laboratory Medicine. 2016 ; 140 341-344.[citado 2024 nov. 04 ] Available from: http://www.archivesofpathology.org/doi/pdf/10.5858/arpa.2015-0506-SAVancouver
Sholl LM, Aisner DL, Allen TC, Beasley MB, Borczuk AC, Cagle PT, Capelozzi V, Dacic S, Hariri L, Kerr KM, Lantuejoul S, Mino-Kenudson M, Raparia K, Rekhtman N, Roy-Chowdhuri S, Thunnissen E, Tsao MS, Yatabe Y. Programmed Death Ligand-1 Immunohistochemistry— A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society [Internet]. Archives of Pathology and Laboratory Medicine. 2016 ; 140 341-344.[citado 2024 nov. 04 ] Available from: http://www.archivesofpathology.org/doi/pdf/10.5858/arpa.2015-0506-SA
